Nilambur Institute Of Medical Science Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 26-05-2024
- Paid Up Capital ₹ 0.18 M
as on 26-05-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.00 Cr
as on 26-05-2024
- Revenue %
(FY 2020)
- Ebitda 83.33%
(FY 2020)
- Net Worth
- Total Assets %
(FY 2020)
About Nilambur Institute Of Medical Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 0.18 M.
The company has closed loans amounting to ₹5.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hamza Ayanikundan, Kunninatu Vasudevan, and Thomas Malayil serve as directors at the Company.
- CIN/LLPIN
U85110KL2005PTC017818
- Company No.
017818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nilambur Institute Of Medical Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunninatu Vasudevan  | Managing Director | 31-Dec-2006 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hamza Ayanikundan | Director | 20-Jan-2005 | Current |
| Thomas Malayil | Director | 20-Jan-2005 | Current |
Financial Performance and Corporate Structure Insights of Nilambur Institute Of Medical Science.
Nilambur Institute Of Medical Science Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nilambur Institute Of Medical Science?
In 2017, Nilambur Institute Of Medical Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kerala Financial Corporation Creation Date: 19 Feb 2010 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Nilambur Institute Of Medical Science?
Unlock and access historical data on people associated with Nilambur Institute Of Medical Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nilambur Institute Of Medical Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nilambur Institute Of Medical Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
